Xiang Gao1, Yongbo Wang2, Guang Sun3. 1. College of Food Science and Engineering, Ocean University of China, Qingdao, Shandong Province, China; Faculty of Medicine, Memorial University, St. John's, NL, Canada. 2. Faculty of Medicine, Memorial University, St. John's, NL, Canada; The Department of Endocrinology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China. 3. Faculty of Medicine, Memorial University, St. John's, NL, Canada. Electronic address: Gsun@mun.ca.
Abstract
OBJECTIVE: Dietary betaine supplement could ameliorate insulin resistance (IR) in animals, but no data are available for choline. Reports on humans are rare. The aim of this study was to investigate the association between dietary choline and betaine intake and IR in humans. METHODS: We assessed 2394 adults from the CODING (Complex Diseases in the Newfoundland population: Environment and Genetics) study. Intake of dietary choline and betaine was evaluated from the Willett Food Frequency Questionnaire. IR was estimated by homeostatic model assessment (HOMA-IR) and the quantitative insulin-sensitivity check index (QUICKI). Partial correlation analysis was used to determine the correlations of dietary choline and betaine intake with IR adjusted for major confounding factors. RESULTS: Dietary choline and betaine intake was inversely correlated with levels of fasting glucose and insulin, HOMA-IR, HOMA-β (r = -0.08 to -0.27 for choline and r = -0.06 to -0.16 for betaine; P < 0.05) and positively related to QUICKI (r = 0.16-0.25 for choline and r = 0.11-0.16 for betaine; P < 0.01) in both sexes after controlling for age, total calorie intake, and physical activity level. The significant associations disappeared in men after percent trunk fat was added as a confounding factor. Furthermore, individuals with the highest tertile of dietary choline and betaine intake had the lowest IR severity. Dietary choline and betaine intake, however, was the lowest in the high IR group, intermediate in the medium group, and the highest in the low IR group. CONCLUSION: This study demonstrated that higher intake of dietary choline and betaine is associated with lower IR in the general population. Copyright Â
OBJECTIVE: Dietary betaine supplement could ameliorate insulin resistance (IR) in animals, but no data are available for choline. Reports on humans are rare. The aim of this study was to investigate the association between dietary choline and betaine intake and IR in humans. METHODS: We assessed 2394 adults from the CODING (Complex Diseases in the Newfoundland population: Environment and Genetics) study. Intake of dietary choline and betaine was evaluated from the Willett Food Frequency Questionnaire. IR was estimated by homeostatic model assessment (HOMA-IR) and the quantitative insulin-sensitivity check index (QUICKI). Partial correlation analysis was used to determine the correlations of dietary choline and betaine intake with IR adjusted for major confounding factors. RESULTS: Dietary choline and betaine intake was inversely correlated with levels of fasting glucose and insulin, HOMA-IR, HOMA-β (r = -0.08 to -0.27 for choline and r = -0.06 to -0.16 for betaine; P < 0.05) and positively related to QUICKI (r = 0.16-0.25 for choline and r = 0.11-0.16 for betaine; P < 0.01) in both sexes after controlling for age, total calorie intake, and physical activity level. The significant associations disappeared in men after percent trunk fat was added as a confounding factor. Furthermore, individuals with the highest tertile of dietary choline and betaine intake had the lowest IR severity. Dietary choline and betaine intake, however, was the lowest in the high IR group, intermediate in the medium group, and the highest in the low IR group. CONCLUSION: This study demonstrated that higher intake of dietary choline and betaine is associated with lower IR in the general population. Copyright Â
Authors: Daniel T Dibaba; Karen C Johnson; Anna M Kucharska-Newton; Katie Meyer; Steven H Zeisel; Aurelian Bidulescu Journal: Diabetes Care Date: 2020-09-08 Impact factor: 19.112
Authors: James A Greenberg; Xinyin Jiang; Lesley F Tinker; Linda G Snetselaar; Nazmus Saquib; Aladdin H Shadyab Journal: Am J Clin Nutr Date: 2021-07-01 Impact factor: 7.045
Authors: Yolandi van der Merwe; Matthew C Murphy; Jeffrey R Sims; Muneeb A Faiq; Xiao-Ling Yang; Leon C Ho; Ian P Conner; Yu Yu; Christopher K Leung; Gadi Wollstein; Joel S Schuman; Kevin C Chan Journal: Neurotherapeutics Date: 2021-04-13 Impact factor: 7.620
Authors: Marissa DiBella; Minu S Thomas; Hana Alyousef; Courtney Millar; Christopher Blesso; Olga Malysheva; Marie A Caudill; Maria Luz Fernandez Journal: Nutrients Date: 2020-10-13 Impact factor: 5.717